U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852638) titled 'CD70-targeted immunoPET Imaging of Malignant Cancers' on Feb. 16.
Brief Summary: This study aims to establish and optimize the cluster of differentiation (CD70)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging method and its physiological and pathological distribution characteristics, based on which the diagnostic efficacy of the above imaging agents in malignant cancers (renal cancer (especially clear cell renal cell carcinoma), lymphoma, or nasopharyngeal carcinoma (NPC)) will be evaluated.
Study Start Date: Dec. 23, 2024
Study Type: INTERVENTIONAL
Condition:
Renal Cancer
Renal Clear Cell...